ZBP1 and neoplasm: In bilateral tumor models, ZBP1 deficiency abrogated the enhanced abscopal response observed in WT tumors treated with RT + ICI + PARP7i, as measured by contralateral tumor growth (Fig. 6b–d, S8a-b) and survival (Fig. 6e–f).